Lippman SM - Search Results

1

A phase II study of interleukin-2 and interferon-alpha in head and neck cancer.

Schantz SP, Dimery I, Lippman SM, Clayman GL, Pellegrino C, Morice R. Schantz SP, et al. Among authors: lippman sm. Invest New Drugs. 1992 Aug;10(3):217-23. doi: 10.1007/BF00877250. Invest New Drugs. 1992. PMID: 1428731 Clinical Trial.

2

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Among authors: lippman sm. J Natl Cancer Inst. 1992 Jul 1;84(13):1039-40. doi: 10.1093/jnci/84.13.1039. J Natl Cancer Inst. 1992. PMID: 1318977 Clinical Trial. No abstract available.

3

Current status of chemoprevention of head and neck cancer.

Benner SE, Lippman SM, Hong WK. Benner SE, et al. Among authors: lippman sm. Oncology (Williston Park). 1992 Aug;6(8):61-6; discussion 66-8, 71 passim. Oncology (Williston Park). 1992. PMID: 1386997 Clinical Trial.

4

Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis.

Benner SE, Lippman SM, Wargovich MJ, Velasco M, Peters EJ, Morice RC, Hong WK. Benner SE, et al. Among authors: lippman sm. Int J Cancer. 1992 Aug 19;52(1):44-7. doi: 10.1002/ijc.2910520110. Int J Cancer. 1992. PMID: 1500226

5

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Among authors: lippman sm. Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v. Cancer. 1991. PMID: 1655220 Clinical Trial.

6

The evaluation of micronuclei as an intermediate endpoint of bronchial carcinogenesis.

Lippman SM, Peters EJ, Wargovich MJ, Dixon DO, Dekmezian RH, Cunningham JE, Loewy JW, Morice RC, Hong WK. Lippman SM, et al. Prog Clin Biol Res. 1990;339:165-77. Prog Clin Biol Res. 1990. PMID: 1697414 No abstract available.

7

13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.

Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU, Hong WK. Lippman SM, et al. J Natl Cancer Inst. 1992 Feb 19;84(4):235-41. doi: 10.1093/jnci/84.4.235. J Natl Cancer Inst. 1992. PMID: 1734084 Clinical Trial.

8

13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.

Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, Holdener E, Krakoff IH. Lippman SM, et al. J Natl Cancer Inst. 1992 Feb 19;84(4):241-5. doi: 10.1093/jnci/84.4.241. J Natl Cancer Inst. 1992. PMID: 1734085 Clinical Trial.

9

Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases.

Fossella FV, Lippman SM, Seitz DE, Alberts DS, Taylor CW, Wiltshaw E, Hardy J, O'Brien M, Haynes TR, Wolen RL. Fossella FV, et al. Among authors: lippman sm. Invest New Drugs. 1991 Nov;9(4):357-9. doi: 10.1007/BF00183581. Invest New Drugs. 1991. PMID: 1804813 Clinical Trial. No abstract available.

10

Chemoprevention in head and neck cancer.

Heyne KE, Lippman SM, Hong WK. Heyne KE, et al. Among authors: lippman sm. Hematol Oncol Clin North Am. 1991 Aug;5(4):783-95. Hematol Oncol Clin North Am. 1991. PMID: 1890067 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

595 results

Search Page

Filters